業績

  • 2016年

    1. Kanae Yamamoto-Nonaka, Masato Koike, Katsuhiko Asanuma, Miyuki Takagi, JuaAlejandroOliva Trejo, Takuto Seki, Teruo Hidaka, Koichiro Ichimura, Tatsuo Sakai, Norihiro Tada, Takashi Ueno, Yasuo Uchiyama, Yasuhiko Tomino: Cathepsin D in Podocytes is Important in the Pathogenesis of Proteinuria and CKD. J. of the American Society of Nephrology, 2016 Sep;27(9):2685-700.

    2. Norihiro Tada, Fumio Kanai, Eri Nakamura, Hongmei Lu, Masahiro Sato: Syngenic grafting of a whole juvenile male gonadal tissue into the adult testes confers successful spermatogenesis in mice. Asian Pacific J of Reprod.2016, 5(4), 279-286.

    3. Takeshita Y, Shibata N, Kasanuki K, Nagata T, Shinagawa S, Kobayashi N, Ohnuma T, Suzuki A, Kawai E, Takayama T, Nishioka K, Motoi Y, Hattori N, Nakayama K, Yamada H, Arai H.　Genetic association between RAGE polymorphisms and Alzheimer’s disease and Lewy body dementias in a Japanese cohort: a case-control study. Int J Geriatr Psychiatry. 2016 Oct 4. doi: 10.1002/gps.4600.

    4. Kobayashi N, Shinagawa S, Nagata T, Shimada K, Shibata N, Ohnuma T, Kasanuki K, Arai H, Yamada H, Nakayama K, Kondo K.Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment. PLoS One. 2016 Dec 19;11(12):e0168816.

    5. Kobayashi I, Takahashi F, Nurwidya F, Nara T, Hashimoto M, Murakami A, Yagishita S, Tajima K, Hidayat M, Shimada N, Suina K, Yoshioka Y, Sasaki S, Moriyama M, Moriyama H, Takahashi K. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells. Biochem Biophys Res Commun. 2016 Apr 22;473(1):125-32.

    6. Asao T, Fujiwara Y, Sunami K, Kitahara S, Goto Y, Kanda S, Horinouchi H, Nokihara H, Yamamoto N, Ichikawa H, Kohno T, Tsuta K, Watanabe S, Takahashi K, Ohe Y. Medical treatment involving investigational drugs and genetic profile of thymic carcinoma. Lung Cancer. 2016 Mar; 93:77-81.

    7. Kato M, Shukuya T, Mori K, Kanemaru R, Honma Y, Nanjo Y, Muraki K, Shibayama R, Koyama R, Shimada N, Takahashi F, Takahashi K. Cerebral infarction in advanced non-small cell lung cancer: a case control study. BMC Cancer. 2016 Mar 10; 16(1):203.

    8. Sasaki S, Yoshioka Y, Ko R, Katsura Y, Namba Y, Shukuya T, Kido K, Iwakami S, Tominaga S, Takahashi K. Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure. Respir Investig. 2016 Jan; 54(1):14-9.

    9. Hayashi T, Kumasaka T, Mitani K, Okada Y, Kondo T, Date H, Chen F, Oto T, Miyoshi S, Shiraishi T, Iwasaki A, Hara K, Saito T, Ando K, Kobayashi E, Gunji-Niitsu Y, Kunogi M, Takahashi K, Yao T, Seyama K. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses. Hum Pathol. 2016 Apr; 50:34-42.

    10. Ando K, Fujino N, Mitani K, Ota C, Okada Y, Kondo T, Mizobuchi T, Kurihara M, Suzuki K, Hoshika Y, Ebana H, Kobayashi E, Takahashi K, Kubo H, Seyama K. Isolation of Individual Cellular Components from Lung Tissues of Patients with Lymphangioleiomyomatosis. Am J Physiol Lung Cell Mol Physiol. 2016 May 15; 310(10):L899-908.

    11. Kato M, Morio Y, Matsunaga T, Shiraishi A, Uekusa T, Takahashi K. Bronchial-pulmonary arterial fistula with primary racemose hemangioma. Respirol Case Rep. 2016 Mar 31;4(2):e00148.

    12. Sekimoto Y, Kato M, Shukuya T, Koyama R, Nagaoka T, Takahashi K. Bevacizumab-induced chronic interstitial pneumonia during maintenance therapy in non-small cell lung cancer. Respirol Case Rep. 2016 Mar 31;4(2):e00151.

    13. Koyama R,Takahashi K.Non-Small-Cell lung cancer treatment: cytotoxic chemotherapy, molecular targeted therapy, and immunotherapy. Juntendo Medical Journal,2016 62(1): 7-12.

    14. Yamada K, Ichiki M, Takahashi K, Hisamatsu Y, Takeoka H, Azuma K, Shukuya T, Nishikawa K,Tokito T,Ishii H, Hoshino T. A multicenter phase II trial of S‑1 combined with bevacizumab after platinum‑based chemotherapy in patients with advanced non‑squamous non‑small cell lung cancer. Cancer Chemother Pharmacol, 2016 Sep;78(3):501-7.

    15. Kato M, Sasaki S, Sekimoto Y, Arano N, Jo H, Suina K, Kuriyama S, Muraki K, Nagashima O, Yoshioka Y, Tominaga S, Takahashi K.Loxoprofen-induced interstitial pneumonia: a case report. J Med Case Rep. 2016 May 25;10(1):128.

    16. Sakurai F, Narii N, Tomita K,Togo S, Takahashi K, Machitani M, Tachibana M, Ouchi M, Katagiri N,Urata Y, Fujiwara T, Mizuguchi H. Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus. Mol Ther Methods Clin Dev. 2016 Mar 2;3:16001.

    17. Jiang L, Konishi H, Nurwidya F, Takahashi F, Ebinuma H, Fujimura K, Takasu K, Jiang M, Bujo H, Daida H. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice. Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1972-9.

    18. Hoshika Y, Takahashi F, Togo S, Hashimoto M, Takeshi N, Kobayashi T, Nurwidya F, Kataoka H, Kurihara M, Kobayashi E, Ebana H, Kikkawa M, Ando K, Nishino K, Hino O, Takahashi K, Seyama K. Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dubé syndrome. Physiological Reports.2016 Nov;4(21).

    19. Ihara H, Tajima K, Yoshikawa H, Tajima M, Harada N, Takahashi F, Uekusa T, Nagaoka T, Takahashi K. Autofluorescence imaging bronchoscopy as a novel approach to the management of tracheobronchopathia osteochondroplastica.J Thorac Dis.2016 Oct;8(10):E1195-E1198.

    20. Atsuta R, To Y, Sakamoto S, Mukai I, Kobayashi A, Kinoshita A, Takahashi K.Assessing usability of the “Adherence Starts with Knowledge 20” (ASK-20) questionnaire for Japanese adults with bronchial asthma receiving inhaled corticosteroids long term.Allergol Int. 2016 Oct 3. pii: S1323-8930(16)30150-2.

    21. Nakashita T, Ando K, Takahashi K, Motojima S.Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients.Respir Investig. 2016 Sep;54(5):376-9.

    22. Kanemaru R, Morio Y, Takekawa H, Jo H, Kasuga F, Koyama R, Shiota S, Nagaoka T, Takahashi K.Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma. Respir Investig. 2016 Sep;54(5):372-5.

    23. Shigematsu M, Koga T, Ishimori A, Saeki K, Ishii Y, Taketomi Y, Ohba M, Jo-Watanabe A, Okuno T, Harada N, Harayama T, Shindou H, Li JD, Murakami M, Hoka S, Yokomizo T. Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.Sci Rep. 2016 Oct 5;6:34560.

    24. Harada S, Harada N, Itoigawa Y, Katsura Y, Kasuga F, Ishimori A, Makino F, Ito J, Atsuta R, Takahashi K.Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.J Asthma. 2016;53(2):207-12.

    25. Valentine Comaills, Rémi Buisson, Robert Morris, Marissa Wells Madden, Lilian Kabeche, Joseph A. LiCausi, Myriam Boukhali, Ken Tajima, Shiwei Pan, Nicola Aceto, Srinjoy Sil, Min Yu, Yu Zheng, Tilak Sundaresan, Toshifumi Yae, Nicole Vincent Jordan, David T, Miyamoto, Sridhar Ramaswamy, Wilhelm Haas, Lee Zou, Daniel A, Haber, and Shyamala Maheswaran. Genomic Instability Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition. Cell Rep, 2016 Dec 6;17(10):2632-2647.

    26. Sato T, Maruyama M, Sugimoto M. Elimination of p19ARF-expressing cells enhances pulmonary function in mice. Hashimoto M, Asai A, Kawagishi H, Mikawa R, Iwashita Y, Kanayama K, Sugimoto K, JCI Insight. 2016 Aug 4;1(12):e87732.

    27. Kurihara M, Mizobuchi T, Kataoka H, Sato T, Kumasaka T, Ebana H, Yamanaka S, Endo R, Miyahashira S, Shinya N, Seyama K. A Total Pleural Covering for Lymphangioleiomyomatosis Prevents Pneumothorax Recurrence.PLoS One. 2016 Sep 22;11(9):e0163637.

    28. Takada T, Mikami A, Kitamura N, Seyama K, Inoue Y, Nagai K, Suzuki M, Moriyama H, Akasaka K, Tazawa R, Hirai T, Mishima M, Hayashida M, Hirose M, Sugimoto C, Arai T, Hattori N, Watanabe K, Tamada T, Yoshizawa H, Akazawa K, Tanaka T, Yagi K, Young LR, McCormack FX, Nakata K. Efficacy and Safety of Long-term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis.Ann Am Thorac Soc. 2016 Nov;13(11):1912-1922.

    29. Seyama K, Hirai T, Mishima M, Tatsumi K, Nishimura M; Respiratory Failure Research Group of the Japanese Ministry of Health, Labour, and Welfare. A nationwide epidemiological survey of alpha1-antitrypsin deficiency in Japan.Respir Investig. 2016 May;54(3):201-6.

    30. Hayashida M, Yasuo M, Hanaoka M, Seyama K, Inoue Y, Tatsumi K, Mishima M; Respiratory Failure Research Group of the Ministry of Health, Labour, and Welfare, Japan. Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: An analysis of the Japanese National Research Project on Intractable Diseases database.Respir Investig. 2016 May;54(3):193-200.

    31. Yoshimi K, Oh S, Suzuki K, Kodama Y, Sekiya M, Seyama K, Fukuchi Y. Impact of Airflow Limitation on Comorbidities and Postoperative Complications in Patients Undergoing Thoracic Surgery: A Retrospective Observational Study. Ann Thorac Cardiovasc Surg. 2016 Jun 20;22(3):146-52.

    32. Ando K, Okada Y, Akiba M, Kondo T, Kawamura T, Okumura M, Chen F, Date H, Shiraishi T, Iwasaki A, Yamasaki N, Nagayasu T, Chida M, Inoue Y, Hirai T, Seyama K, Mishima M, Respiratory Failure Research Group of the Japanese Ministry of Health, Labour, and Welfare. Lung Transplantation for Lymphangioleiomyomatosis in Japan. PLoS One. 2016 Jan 15;11(1):e0146749.

    33. Fujita A, Ando K, Kobayashi E, Mitani K, Okudera K, Nakashima M, Miyatake S, Tsurusaki Y, Saitsu H, Seyama K, Miyake N, Matsumoto N. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing. Hum Genet. 2016 Jan;135(1):61-8.

    34. Ebana H, Otsuji M, Mizobuchi T, Kurihara M, Takahashi K, Seyama K.Pleural Covering Application for Recurrent Pneumothorax in a Patient with Birt-Hogg-Dubé Syndrome. Ann Thorac Cardiovasc Surg. 2016 Jun 20;22(3):189-92.

    35. Hashimoto Y, Sugiura H, Togo S, Koarai A, Abe K, Yamada M, Ichikawa T, Kikuchi T, Numakura T, Onodera K, Tanaka R, Sato K, Yanagisawa S, Okazaki T, Tamada T, Kikuchi T, Hoshikawa Y, Okada Y, Ichinose M. 27-Hydroxycholesterol accelerates cellular senescence in human lung resident cells.Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1028-41.

    36. Shukuya T, Mori K, Amann JM, Bertino EM, Otterson GA, Shields PG, Morita S, Carbone DP. Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Antibodies. J Thorac Oncol. 2016 Nov;11(11):1927-1939.

    37. Sawada T, Watanabe M, Fujimura Y, Yagishita S, Shimoyama T, Maeda Y, Kanda S, Yunokawa M, Tamura K, Tamura T, Minami H, Koh Y, Koizumi F. Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells.Cancer Sci. 2016 Mar;107(3):307-14.

    38. Yamane Y, Shiono A, Ishii Y, Isobe K, Miyauchi E, Kishi K, Nishino M, Sugawara S, Ko R, Koyama N, Yabuki Y, Kobayashi K.Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan. Jpn J Clin Oncol. 2016 Dec;46(12):1135-1142.

    39. Katsuya Y, Horinouchi H, Asao T, Kitahara S, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Watanabe S, Tsuta K, Ohe Y. Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy. Lung Cancer. 2016 Sep;99:4-10.

    40. Kato M, Sasaki S, Izumi H, Uekusa T, Tominaga S, Takahashi K. Development of diffuse alveolar damage after initiation of Nijutsuto. Respirol Case Rep. 2016 Oct 25;4(6):e00195.

    41. Hara M, Iwakami SI, Matsumoto N, Miyawaki T, Wada R, Takahashi K. Carcinomatous pleuritis and pericarditis accompanied by pulmonary tuberculosis. Respirol Case Rep. 2016 Oct 31;4(6):e00202.

    42. Ogita M, Miyauchi K, Onishi A, Tsuboi S, Wada H, Konishi H, Naito R, Dohi T, Kasai T, Kojima Y, Schwartz R, Daida H. Accelerated coronary atherosclerotic model in a novel low density lipoprotein receptor knock-out swine. PLoS One. 2016 Sep 15;11(9):e0163055.

    43. Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R, Dohi T, Tamura H, Okazaki S, Daida H. Adequate time in therapeutic INR range using triple antithrombotic therapy is not associated with long-term cardiovascular events and major bleeding complications after drug-eluting stent implantation J Cardiol. 2016 Dec;68(6):517-522.

    44. Naito R, Miyauchi K, Konishi H, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Appropriate level of low density lipoprotein cholesterol for secondary prevention of coronary artery disease. J Atheroscler Thromb. 2016;23(4):413-21.

    45. Shimada K, Daida H.Are there any“ultimate”practices for preventing atherosclerotic diseases. Juntendo Medical Journal. 2016 62:217-223.

    46. Nishizaki Y, Shimada K, Tani S, Ogawa T, Ando J, Takahashi M, Yamamoto M, Shinozaki T, Miyazaki T, Miyauchi K, Nagao K, Hirayama A, Yoshimura M, Komuro I, Nagai R, Daida H. Association between the docosahexaenoic acid to arachidonic acid ratio and acute coronary syndrome: a multicenter observational study. BMC Cardiovasc Disord. 2016 Jul 7;16(1):143.

    47. Naito R, Miyauchi K, Shitara J, Endo H, Wada H, Doi S, Konishi H, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Combined Effect of Body mass index and Renal Function on Long-term Clinical Outcomes in the Elderly following Percutaneous Coronary Intervention. J Am Geriatr Soc. 2016 Sep;64(9):e39-41.

    48. Naito R, Miyauchi K, Konishi H, Tsuboi S, Ogita M, Dohi T, Kajimoto K, Kasai T, Tamura H, Okazaki S, Isoda K, Yamamoto T, Amano A, Daida H. Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease. Heart Vessels.2016 Sep;31(9):1424-9.

    49. Tamura H, Miyauchi K, Dohi T, Tsuboi S, Ogita M, Kasai T, Okai I, Katoh Y, Miyazaki T, Naito R, Konishi H, Yokoyama K, Okazaki S, Isoda K, Kurata T, Daida H. Comparison of Clinical and Angiographic Outcomes After Bare Metal Stents and Drug-Eluting Stents Following Rotational Atherectomy. Int Heart J. 2016; 57: 150-157.

    50. Wada H, Ogita M, Miyauchi K, Tsuboi S, Konishi H, Shitara J, Kunimoto M, Sonoda T, Iso T, Ebina H, Aoki E, Kitamura K, Tamura H, Suwa S, Daida H. Contemporary sex differences among patients with acute coronary syndrome treated by emergency percutaneous coronary intervention. Cardiovasc Interv Ther. 2016 Aug 8.

    51. Okazaki S, Daida H. Current Catheter Intervention for Various Cardiovascular Disease. Juntendo Medical Journal 2016 62(3) ,197-208.

    52. Daida H, Nishitani-Yokoyama M, Shimada K. Current Status and Future Directions for Cardiac Rehabilitation in Japan. Juntendo Medical Journal. 2016 62 (Supple 1):29-37.

    53. Jiang L, Konishi H, Nurwidya F, Satoh K, Takahashi F, Ebinuma H, Fujimura K, Takasu K, Jiang M, Shimokawa H, Bujo H, Daida H. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice. Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1972-9.

    54. Fujimoto S, Daida H. Development in coronary CT angiography. Juntendo Medical Journal. 2016;62:190-196.

    55. Naito R, Miyauchi K, Konishi H, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Gender difference in long-term clinical outcomes following percutaneous coronary intervension during 1984-2008. Atherosclerosis. 2016 Apr;247:105-10.

    56. Konishi H, Miyauchi K, Shitara J, Endo H, Wada H, Doi S, Naito R, Tsuboi S, Ogita M, Dohi T, Kasai T, Okazaki S, Isoda K, Suwa S, Daida H. Impact of lipoprotein(a) on long-term outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention. Am J Cardiol. 2016 Dec 15;118(12):1781-1785.

    57. Konishi H, Miyauchi K, Naito R, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Impact of stent length on clinical outcomes of first-generation and new-generation drug-eluting stents. Cardiovasc Interv Ther. 2016 Apr;31(2):114-21.

    58. Naito R, Miyauchi K, Daida H, Morimoto T, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Matsuzaki M, JAPAN-ACS Investigators. Impact of Total Risk Management on Coronary Plaque Regression in Diabetic Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2016 Aug 1;23(8):922-31.

    59. Sai E, Shimada K, Miyauchi K, Masaki Y, Kojima T, Miyazaki T, Kurata T, Ogita M, Tsuboi S, Yoshihara T, Miyazaki T, Ohsaka A, Daida H. Increased cystatin-C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents. Heart Vessels. 2016 May;31(5):694-701.

    60. Takamura K, Kondo T, Fujimoto S, Hiki M, Matsumori R, Kawaguchi Y, Amanuma M, Takase S, Daida H. Incremental predictive value for obstructive coronary artery disease by combination of Duke Clinical Score and Agatston score. Eur Heart J Cardiovasc Imaging. Eur Heart J Cardiovasc Imaging. 2016 May;17(5):550-6.

    61. Fujimoto S, Kondo T, Takamura K, Baber U, Shinozaki T, Nishizaki Y, Kawaguchi Y, Matsumori R, Hiki M, Miyauchi K, Daida H, Hecht H, Stone GW, Narula J. Incremental prognostic value of coronary computed tomographic angiography high-risk plaque characteristics in newly symptomatic patients. J Cardiol. 2016 Jun;67(6):538-44.

    62. Akita K, Isoda K, Okabayasi Y, Shimada K, Daida H. Lack of IkBNS accelarates atherosclerosis in LDL receptor-deficinet mice via increased interleukin-6 production. Int J Cardiol. 2016 May 15;211:61-3.

    63. Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R, Nishizaki Y, Okai I, Tamura H, Okazaki S, Isoda K, Daida H. Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis. Heart Vessels. 2016 Apr;31(4):441-8.

    64. Takahashi S, Shimada K, Miyauchi K, Miyazaki T, Sai E, Ogita M, Tsuboi S, Tamura H, Okazaki S, Shiozawa T, Ouchi S, Aikawa T, Kadoguchi T, Al Shahi H, Yoshihara T, Hiki M, Isoda K, Daida H. Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention. Cardiovasc Diabetol. 2016 Oct 11;15(1):145.

    65. Shimizu M, Miyazaki T, Takagi A, Kasai T, Hayashi H, Hiki M, Takahashi S, Aikawa T, Ouchi S, Suda S, Kato T, Murata A, Yatsu S, Sugita Y, Shimada K, Miyauchi K, Daida H. Low circulating coenzyme Q10 during acute phase is associated with inflammation, malnutrition, and in hospital mortality in patients admitted to the coronary care unit. Heart Vessels. 2016 Dec 9.

    66. Konishi H, Miyauchi K, Tsuboi S, Naito R, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Plasma lipoprotein(a) predicts major cardiovascular events in patients with chronic kidney disease who undergo percutaneous coronary intervention. Int J Cardiol.2016 Feb 15;205:50-3.

    67. Wada, H, Dohi T, Miyauchi K, Shitara J, Endo H, Doi S, Naito R, Konishi H, Tsuboi S, Ogita M, Kasai T, Hassan A, Okazaki S, Isoda K, Shimada K, Suwa S, Daida H. Preprocedural high-sensitivity C-reactive protein predicts long-term outcomes in patients undergoing percutaneous coronary intervention. Circ J. 90-95:81;2017.

    68. Ogita M, Miyauchi K, Jiang M, Kasai T, Tsuboi S, Naito R, Konishi H, Dohi T, Yokoyama T, Okazaki S, Shimada K, Suwa T, Bujo H, Daida H. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease. Atherosclerosis. 2016 Jan;244:216-21.

    69. Hassan A, Dohi T, Miyauchi K, Ogita M, Kurano M, Ohkawa R, Nakamura K, Tamura H, Isoda K, Okazaki S, Yatomi Y, Daida H. Prognostic impact of homocysteine levels and homocysteine thiolactonase activity on long-term clinical outcomes in patients undergoing percutaneous coronary intervention. J Cardiol. 2016 Sep 27. pii: S0914-5087(16)30 207-6 2017

    70. Tadaki S, Sakata Y, Miura Y, Miyata S, Asakura M, Shimada K, Yamamoto T, Fukumoto Y, Kadokami T, Yasuda S, Miura T, Ando S, Yano M, Kitakaze M, Daida H, Shimokawa H. Prognostic Impacts of Metabolic Syndrome in Patients with Chronic Heart Failure -A Multicenter Prospective Cohort Study. Circ J. 2016;80(3):677-88.

    71. Onda T, Inoue K, Suwa S, Nishizaki Y, Kasai T, Kimura Y, Fukuda K, Okai I, Fujiwara Y, Matsuoka J, Sumiyoshi M, Daida H. Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era. Int J Cardiol. 2016 Sep 15;219:180-5.

    72. Takeno K, Tamura Y, Kawaguchi M, Kakehi S, Watanabe T, Funayama T, Kaga H, Yamamoto R Kim M, Nishitani M, Shimada K, Daida H, Aoki S, Taka H, Fujimura T, Sawada S, Giacca A, Kanazawa A, Fujitani Y, Kawamori R, Watada H. Relation between insulin sensitivity and metabolic abnormalities in Japanese men with BMI of 23-25 kg/m2. J Clin Endocrinol Metab. 2016 Oct;101(10):3676-3684.

    73. Shibayama K, Daimon M, Watanabe H, Kawata T, Miyazaki S, Morimoto-Ichikawa R, Maruyama M, Chiang SJ, Miyauchi K, Daida H. Significance of Coronary Artery Disease and Left Ventricular Afterload in Unoperated Asymptomatic Aortic Stenosis. Circ J. 2016;80(2):519-25.

    74. Naito R, Miyauchi K, Konishi H, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Temporal Trends in Clinical Outcome After Percutaneous Coronary Intervention 1984-2010 – Report From the Juntendo PCI Registry. Circ J. 2016;80(1):93-100.

    75. Naito R, Miyauchi K, Shitara J, Endo H, Wada H, Doi S, Konishi H, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Temporal trends in clinical outcomes following percutaneous coronary intervention in patients with renal insufficiency. J Atheroscler Thromb. 2016 Sep 1;23(9):1080-8.

    76. Naito R, Miyauchi K, Konishi H, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Temporal trends in the Clinical Outcomes after Percutaneous Coronary Intervention from 1984 to 2010 -Report from the Juntendo PCI Registry- Circ J. 2016 Sep 1;23(9):1080-8.

    77. Chiang SJ, Daimon M, Miyazaki S, Kawata T, Morimoto-Ichikawa R, Maruyama M, Ohmura H, Miyauchi K, Lee SL, Daida H. When and how aortic stenosis is first diagnosed: A single-center observational study. J Cardiol. 2016 Oct;68(4):324-8.

    78. Hirose S, Osada T, Ogawa A, Tanaka M, Wada H, Yoshizawa Y, Imai Y, Machida T, Akahane M, Shirouzu I, and Konishi S. Lateral-medial dissociation in orbitofrontal cortex-hypothalamus connectivity. Frontiers in Human Neuroscience, 2016 May 26;10:244.

    79. Jimura K., Hirose S., Wada H., Yoshizawa Y., Imai Y., Akahane M., Machida T., Shirouzu I., Koike Y., Miyashita Y., Konishi S. Relatedness-dependent rapid development of brain activity in anterior temporal cortex during pair-association retrieval. Neuroscience Letters, 2016 Aug 3;627:24-9.

    80. Miyajima M, Kazui H, Mori E, Ishikawa M: One-Year Outcome in Patients with Idiopathic Normal-Pressure Hydrocephalus: Comparison of Lumbo-Peritoneal Shunt to Ventriculo-Peritoneal Shunt. J Neurosurg. 2016 Dec;125(6):1483-1492.

    81. Kamiya K, Kamagata K, Miyajima M, Nakajima M, Hori M, Tsuruta K, Mori H, Kunimatsu A, Arai H, Aoki S, Ohtomo K. Diffusional Kurtosis Imaging in Idiopathic Normal Pressure Hydrocephalus: Correlation with Severity of Cognitive Impairment. Magn Reson Med Sci. 2016 Jul 11;15(3):316-23.

    82. Yoshihara A, Fukatsu M, Hoshi K, Ito H, Nollet K, Yamaguchi Y, Ishii R, Tokuda T, Miyajima M, Arai H, Kato T, Furukawa K, Arai H, Kikuchi A, Takeda A, Ugawa Y, Hashimoto Y. Subgroup differences in “brain-type” transferrin and α-synuclein in Parkinson’s disease and multiple system atrophy. J Biochem. 2016 Aug;160(2):87-91.

    83. Yamada S, Kimura T, Jingami N, Atsuchi M, Hirai O, Tokuda T, Miyajima M, Kazui H, Mori E, Ishikawa M, SINPHONI-2 Investigators. Disability risk or unimproved symptoms following shunt surgery in patients with idiopathic normal-pressure hydrocephalus: post hoc analysis of SINPHONI-2. J Neurosurg. 2016 Jul 15:1-8.

    84. Kimura T, Schulz M, Shimoji K, Miyajima M, Arai H, Thomale UW. In vitro performance of the fixed and adjustable gravity-assisted unit with and without motion-evidence of motion-induced flow. Acta Neurochir (Wien). 2016 Oct;158(10):2011-8.

    85. Sato H, Takahashi Y, Kimihira L, Iseki C, Kato H, Suzuki Y, Igari R, Sato H, Koyama S, Arawaka S, Kawanami T, Miyajima M, Samegima N, Sato S, Kameda M, Yamada S, Kaijima M, Date I, Sonoda Y, Kayama T, Kuwana N, Arai H, Kato T. A segmental copy number loss of the SFMBT1 gene is a genetic risk for shunt-responsive idiopathic normal pressure hydrocephalus (iNPH): a case-control study. PloS One. 2016 Nov 18;11(11):e0166615.

    86. Mitome-Mishima Y, Oishi H, Yamamoto M, Yatomi K, Nonaka S, Miyamoto N, Urabe T, Arai H. Differences in tissue proliferation and maturation between Matrix2 and bare platinum coil embolization in experimental swine aneurysms.J Neuroradiol. 2016 Feb;43(1):43-50..

    87. Takamura S, Ikeda A, Nishioka K, Furuya H, Tashiro M, Matsushima T, Li Y, Yoshino H, Funayama M, Morinobu S, Hattori N. Schizophrenia as a prodromal symptom in a patient harboring SNCA duplication. Parkinsonism Relat Disord. 2016 Apr;25:108-9.

    88. Conedera S, Apaydin H, Li Y, Yoshino H, Ikeda A, Matsushima T, Funayama M, Nishioka K, Hattori N. FBXO7 Mutations in Parkinson’s Disease and Multiple System Atrophy. Neurobiol Aging. 2016 Apr;40:192.e1-5.

    89. Kamagata K, Kerever A, Yokosawa S, Otake Y, Ochi H, Hori M, Kamiya K, Tsuruta K, Tagawa K, Okazawa H, Aoki S, Arikawa-Hirasawa E. Quantitative Histological Validation of Diffusion Tensor MRI with Two-Photon Microscopy of Cleared Mouse Brain.Magn Reson Med Sci.2016 Oct 11;15(4):416-421.

    90. Sato S, Koike M, Funayama F, Ezaki J, Fukuda T, Uenn T, Uchiyama U, Hattori N. Lysosomal storage of subunit c of mitochondrial ATP synthase in brain-specific Atp13a2-deficient mice. Am J Pathol. 2016 Dec;186(12):3074-3082.

    91. Yamanaka T, Tosaki A, Miyazaki H, Kurosawa M, Koike M, Uchiyama Y, Maity SN, Misawa H, Takahashi R, Shimogori T, Hattori N, Nukina N. Differential roles of NF-Y transcription factor in ER chaperone expression and neuronal maintenance in the CNS. Sci Rep. 2016 Sep 30;6:34575.

    92. Hadano S, Mitsui S, Pan L, Otomo A, Kubo M, Sato K, Ono S, Onodera W, Abe K, Chen X, Koike M, Uchiyama Y, Aoki M, Warabi E, Yamamoto M, Ishii T, Yanagawa T, Shang H, Yoshii F. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: Cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hum Mol Genet. 2016 Aug 1;25(15):3321-3340.

    93. Sunabori T, Koike M, Asari A, Oonuki Y, Uchiyama Y. Suppression of ischemia-induced hippocampal pyramidal neuron death by hyaluronan tetrasaccharide through inhibition of toll-like receptor 2 signaling pathway. Am J Pathol. 2016 Aug;186(8):2143-51.

    94. Shibata M, Koike M, Kusumi K, Sato N, Uchiyama U. A specific tripeptidyl substrate for tripeptidyl peptidase activity is effectively hydrolyzed by alanyl aminopeptidase/aminopeptidase N/CD13 in the rat kidney. Arch Histol Cytol. 76: 1-8.

    95. Sekine S, Yao A, Hattori K, Sugawara S, Naguro I, Koike M, Uchiyama Y, Takeda K, Ichijo H. The ablation of mirochondrial protein phosphatase Pgam5 confers resistance against metabolic stress. EBioMedicine, 2016 Jan 29;5:82-92.

    96. klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1-222.

    97. Xie C, Ginet V, Sun Y, Koike M, Zhou K, Li T, Li H, Li Q, Wang X, Uchiyama Y, Truttmann AC, Kroemer G, Puyal J, Blomgren K, Zhu C. Neuroprotection by selective neuronal deletion of autophagy-related gene 7 in neonatal brain injury. Autophagy. 2016;12(2):410-23.

    98. Mehanna S, Suzuki C, Shibata M, Sunabori T, Imanaka T, Araki K, Yamamura K, Uchiyama Y, Ohmuraya M. Cathepsin D in pancreatic acinar cells is implicated in cathepsins B and L degradation, but not in autophagic activity. Biochem Biophys Res commun. 2016 Jan 15;469(3):405-11.